0.5358
2.19%
-0.012
Finanzdaten der Spruce Biosciences Inc-Aktie (SPRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
30.65%
2.002
|
2.887 | 3.073 | 2.165 | 1.964 |
Operating Expenses
|
4.16%
14.63
|
14.05 | 16.73 | 16.14 | 15.16 |
Interest Income/Expense |
8.49%
0.097
|
0.106 | 0.119 | 0.127 | 0.131 |
Benefits Costs and Expenses |
6.15%
13.63
|
12.84 | - | - | 14.76 |
Costs And Expenses |
6.15%
13.63
|
12.84 | 16.73 | 16.14 | 14.76 |
Depreciation and Amortization |
6.25%
0.015
|
0.016 | 0.017 | 0.018 | 0.019 |
Operating Income/Loss |
13.16%
-12.63
|
-11.16 | -13.66 | -13.97 | -13.20 |
Income/Loss From Continuing Operations Before Tax |
16.83%
-11.62
|
-9.95 | 3.073 | 2.165 | -12.79 |
Income/Loss From Continuing Operations After Tax |
16.83%
-11.62
|
-9.95 | -12.35 | -12.82 | -12.79 |
Net Income/Loss
|
16.83%
-11.62
|
-9.95 | -12.35 | -12.82 | -12.79 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
5,319%
41.10
|
0.7584 | 40.71 | 40.55 | 31.90 |
Diluted Average Shares |
5,319%
41.10
|
0.7584 | 40.71 | 40.55 | 31.90 |
Basic Earnings Per Share |
21.74%
-0.28
|
-0.23 | -0.30 | -0.32 | -0.40 |
Diluted Earnings Per Share |
21.74%
-0.28
|
-0.23 | -0.30 | -0.32 | -0.40 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):